Advances in AI — October 2026
The item summarizes the top AI-related news and research in radiology over the past month.
Read the original →Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
The item summarizes the top AI-related news and research in radiology over the past month.
Read the original →A new AI system called REDMOD identified hidden warning signs an average of 475 days before diagnosis. It was nearly twice as sensitive as experienced radiologists. It is intended to help doctors detect pancreatic cancer at its earliest stages.
Read the original →Agendia presented data on an AI pathology model. The model predicts breast cancer recurrence risk from routine biopsy slides.
Read the original →Rachel George writes that AI partnerships risk becoming a form of tied aid. She argues they could bind recipients to the priorities, standards, and suppliers of tech donors.
Read the original →A machine learning model was trained on ICU data from two databases. It predicts 28-day mortality in sepsis patients with diabetic retinopathy, with AUCs of 0.805 to 0.870 across validation sets.
Read the original →Mulk Technology announced an AI-enabled digital healthcare platform for India and international markets. It follows a strategic partnership with OnClarity USA signed in Dubai on 23 October 2026. The platform combines Mulk Technology’s Hospital Management System with OnClarity USA’s AI-based patient experience tools.
Read the original →A Baltimore hospital worker uploaded 3,182 patients’ records to an unapproved AI tool. Deleting the chat may not have erased them.
Read the original →At the 2026 WEDI National Conference, HSCC task group co-leads Bill Reid and Ed Gaudet outlined a practical approach to AI governance. The approach addresses cybersecurity and clinical risk.
Read the original →Cleveland Clinic is recognized in the Healthcare and Life Sciences category. The recognition is for its work with Dyania Health's Synapsis Artificial Intelligence (AI) Platform.
Read the original →Andy Craggs, head of energy finance at Paragon SME Lending, writes that healthcare is emerging as one of the biggest beneficiaries of AI.
Read the original →This is a monthly column on biotech for founders and builders in Central and Eastern Europe. The first installment asks why cheaper design has not led to cheaper drugs.
Read the original →Pharmacists can pair advanced medical devices such as digital blood pressure monitors with emerging AI tools to enhance routine counseling with personalized patient education. Combining intelligent technology with direct pharmacist guidance is described as giving patients deeper health insights and supporting better self-management between clinical visits.
Read the original →Heartflow, the incumbent in AI plaque analysis and FFR-CT, has again turned to legal action to defend its cardiac CT software market share. It is suing Elucid for patent infringement and trade secret theft.
Read the original →AI helps detect difficult lesions, aids in diagnosis and drug development. Algorithmic errors can be dangerous if doctors become overly reliant on the technology.
Read the original →The piece describes a study as serendipitous evidence for the case on AI alignment.
Read the original →Agentic AI is moving biopharma from tools that inform decisions to systems that execute them. It is reshaping discovery, clinical trials, commercial launch and regulatory work.
Read the original →Precision, a medical AI startup in Bunkyo, Tokyo, announced on October 26 that additional training cut the share of suspected hallucinated disease names by about 80% in its medical-specific large language model SIP-jmed-LLM-Precision. The company will also sell a Japanese input software product using this research, "Kyo no Iryo AI Nihongo Nyuryoku (Precision IME-med)", from October.
Read the original →"DXCruise", jointly operated by ASTRO Siblings and Shijuman-do, began offering the generative AI diagnostic service "AI Business Navi" for small and medium-sized companies on October 26. Fees are quoted individually, and the diagnosis content and cost are explained before a request is made.
Read the original →